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Abstract: In ageing tissues, long-lived extracellular matrix (ECM) proteins are susceptible to the
accumulation of structural damage due to diverse mechanisms including glycation, oxidation and
protease cleavage. Peptide location fingerprinting (PLF) is a new mass spectrometry (MS) analysis
technique capable of identifying proteins exhibiting structural differences in complex proteomes.
PLF applied to published young and aged intervertebral disc (IVD) MS datasets (posterior, lateral
and anterior regions of the annulus fibrosus) identified 268 proteins with age-associated structural
differences. For several ECM assemblies (collagens I, II and V and aggrecan), these differences were
markedly conserved between degeneration-prone (posterior and lateral) and -resistant (anterior)
regions. Significant differences in peptide yields, observed within collagen I α2, collagen II α1 and
collagen V α1, were located within their triple-helical regions and/or cleaved C-terminal propeptides,
indicating potential accumulation of damage and impaired maintenance. Several proteins (collagen V
α1, collagen II α1 and aggrecan) also exhibited tissue region (lateral)-specific differences in structure
between aged and young samples, suggesting that some ageing mechanisms may act locally within
tissues. This study not only reveals possible age-associated differences in ECM protein structures
which are tissue-region specific, but also highlights the ability of PLF as a proteomic tool to aid in
biomarker discovery.
Keywords: proteomics; peptide location fingerprinting; extracellular matrix; ageing; intervertebral
disc; spine; mass spectrometry
1. Introduction
Intervertebral discs (IVDs) are fibrocartilaginous cushions residing between vertebrae,
which confer flexibility and stability to the spinal column and function as effective shock
absorbers over an individual’s lifetime [1]. Age-associated degeneration of the IVD in the
lower lumbar spine is the leading cause of lower back pain within an ageing population [2],
imposing major socioeconomic and healthcare burdens.
IVDs (located between the endplates of vertebrae) consist of two extracellular matrix
(ECM)-rich tissue compartments: (i) a central gel-like nucleus pulposus (NP), composed
predominantly of the chondroitin sulphate proteoglycans (CSPGs) aggrecan and versican,
Int. J. Mol. Sci. 2021, 22, 10408. https://doi.org/10.3390/ijms221910408 https://www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2021, 22, 10408 2 of 17
and a relatively disordered network of collagen II and (ii) an encircling annulus fibrosus
(AF) consisting of highly ordered, concentric rings (lamellae) of parallel collagen I and
elastic fibres arranged in a crisscross pattern [3,4]. These compartments are large, avascular
and subject to mechanical loads, creating a challenging environment for tissue repair and
regeneration (mediated mainly by a small population of chondrocyte-like cells in the NP
and fibroblast-like cells in the AF [5]). Crucially, regional differences in ECM composition
exist within the AF. ECM components within the inner AF reflect the interface between
the NP and outer AF, being comprised of not only collagen I fibrils but also CSPGs and
collagen II fibrils [4,6].
Clinically, the onset and progression of IVD ageing and degeneration is characterised
typically by a gradual reduction of hydration, pressure and height of the NP and the
formation of tears in AF lamellae making the disc more prone to bulging, protrusion or
herniation [7]. This structural damage to the AF, and hence susceptibility to failure, is
profoundly regional, with degeneration mainly localised in the posterior-lateral portion of
the IVD [8,9]. The dynamic alteration in ECM composition and abundance likely underpins
this regional progression of IVD ageing and degeneration, with decreasing levels of CSPGs
in both the NP and the AF and increasing levels of collagen I fibres, leading to a fibrotic,
dehydrated phenotype [4,10–13]. Additionally, we previously showed that the protein
composition of the inner AF becomes gradually more similar to that of the outer AF with
ageing [13]. It is clear, therefore, that understanding the mechanisms and consequences of
ECM remodelling is key to defining and potentially reversing IVD degeneration and ageing.
ECM assemblies and components can be long-lived, with biological half-lives mea-
sured in years or decades. For example, lung elastic fibres and collagens in cartilaginous
tissues remain present throughout the life of an individual [14,15]. Consequently, ECM
assemblies residing in the IVD (such as collagen I in the AF [16] and aggrecan in the
NP [17]) are susceptible to the progressive accumulation of damage to both their molecular
structures and networks over time, leading to loss of functions of many diverse ECM
components. The potential causative mechanisms of this remodelling include the chronic
exposure of ECM proteins to elevated protease-mediated cleavage [18], cross-linking by
sugars leading to advanced glycation end products (AGEs) [19], mechanical fragmenta-
tion [20] and oxidation by reactive oxygen species (ROS) [21]. These processes may lead to
a spectrum of modifications to protein higher order structures that are challenging to detect.
Although several proteomics studies have characterised IVD ageing and degeneration
through changes in protein presence and abundance alone [12,13,22–24], the identification
of ECM proteins susceptible to damage modifications to their structure is also crucial both
for the discovery of novel ageing biomarker candidates and for deciphering the underlying
mechanisms involved.
Peptide location fingerprinting (PLF) is a new computational technique capable of
identifying proteins exhibiting structural differences in mass spectrometry (MS) datasets
derived from complex biological samples regardless of the causal mechanisms [25]. In
standard proteomics, proteins are exposed to enzymes (e.g., trypsin), generating peptides
whose sequence identities and relative abundances are then measured by liquid chro-
matography tandem MS (LC–MS/MS). PLF relies on the fact that, for a given protein, the
pattern of peptides detected by LC–MS/MS following protease digestion is determined
by its higher order structure and reflects its solubility, stability and enzyme susceptibil-
ity. Therefore, differences in protein structure, due to either the accumulation of damage
(via ageing and disease), changes in interaction states with other protein or differential
synthesis may be detected by PLF [25–27]. This is particularly true for the highly insol-
uble ECM proteins that exist within tightly bound networks. In standard LC–MS/MS,
peptides are mapped to proteins, enabling the quantification of protein abundance. PLF
maps and quantifies peptides (by spectral counting) within specific protein regions instead,
enabling the detection of statistical differences along the primary structure (peptide yield
patterns) [25,26]. Previously, we used PLF to reproducibly detect UVR-induced damage
within the structures of photosensitive skin ECM proteins in vitro [26] and tissue-specific
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differences in eye (ciliary zonule) and skin fibrillin-1 [27]. Crucially, and most recently, we
have developed and employed an online webtool (MPLF) to identify potential proteins
with structural differences between photoaged and photo-protected skin and young and
aged tendon [25]. Comparisons with conventional protein quantification also revealed that
PLF identifies significant differences, which are unique to the methodology, particularly
in ECM proteins, demonstrating that modifications to protein structure may not correlate
with protein abundance in damage-susceptible long-lived proteins [25].
Recently, we have also published DIPPER, a detailed spatiotemporal proteomic analy-
sis of the ageing and degenerating human IVD, which included high-resolution label-free
LC–MS/MS performed on 11 separate regions of discs sourced from two male cadaveric
lumbar spines, one young (16 years old) and one aged (59 years old) [13]. This study
revealed novel, region-specific differences in ECM proteome (matrisome) composition and
abundance, which demonstrated a dynamic shift along the lateral and anteroposterior
axes, with a rapid decline of NP proteins and an increase in AF proteins in the aged inner
AF. Although this proteomic study was highly detailed, modification-related differences
to ECM protein structures were not interrogated. Since degeneration in the ageing disc
is profoundly regional [8,9], and PLF can be applied post hoc to historical LC–MS/MS
data (as shown for ageing tendon [25]), further analysis of the DIPPER dataset presents us
with a timely opportunity to test: (i) the hypothesis that protein structures (as indicated by
peptide yield pattern) are spatially and potentially age-dependent in the IVD and (ii) the
ability of PLF to detect protein structural differences within localised tissue regions.
As the inner AF appeared particularly susceptible to matrisomal changes [13], we
applied PLF to LC–MS/MS datasets corresponding to the inner AFs of three distinct
IVD regions (posterior, left lateral and anterior; Figure 1a). This enabled the detection
of structural differences in ECM proteins between aged and young IVDs, which could
be further compared between degeneration-prone (posterior and lateral) and -resistant
(anterior) regions of the IVD (Figure 1b), revealing potentially age-affected proteins with
tissue region-specific peptide yield patterns. Please note, in the following text and figures,
proteins are commonly referred to by their gene name (indicated by italics).
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Figure 1. Experimental design for the application of PLF to three distinct regions of young and
aged IVDs. (a) Raw LC–MS/MS datasets (from two males, one young [16 years old] and one aged
[59 years old]), corresponding to the posterior inner AF/NP, left lateral inner AF and anterior inner
AF/NP regions of the L3/4, L4/5 and L5/S1 lower lumbar IVDs were downloaded from the PRIDE
repository (PXD017740) [13]. (b) After MS/MS peptide identification, the MPLF webtool [25] was
used to perform PLF on the identified peptides and compare peptide yields across protein structures
between young and aged discs—three vs. three discs for anterior and left lateral datasets and three
vs. two discs for posterior datasets (the young anterior L4/5 disc was omitted from the analysis
due to the insufficient number of identified peptides for PLF analysis). As previously described [25],
((b), i) proteins were divided into 50-amino acid (aa)-sized segments; the collagen I α2 chain (COL1A2)
is shown here as an example. ((b), ii) Peptides were mapped to their respective segments, summed,
normalised between aged and young groups based on the median whole protein spectrum count and
averaged for each group (average peptide spectrum match [PSM] count per segment). ((b), iii) Peptide
yields in each segment were statistically compared between young and aged IVDs using an unpaired,
Bonferroni-corrected, repeated-measures ANOVA (* p ≤ 0.05; *** p ≤ 0.001). To visualise these
differences along the protein structure, average PSM counts per segment in the young group were
subtracted from those in the aged one and compared between posterior, left lateral and anterior IVD
regions.
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2. Results and Discussion
2.1. Peptide Location Fingerprinting Reveals Proteins with Region-Specific Differences between
Aged and Young IVDs
MS/MS peptide searches identified 260 posterior, 391 left lateral and 303 anterior
inner AF-specific proteins in both young and aged groups (Figure S1; peptide reports:
Tables S1–S3). Principal component analyses of peptide spectral counts demonstrated
clear separations of data between young and aged discs for all three IVD regions tested
(Figure S2), reflecting a global compositional difference in ageing similar to that show-
cased previously in the DIPPER study [13]. PLF analysis identified a combined total of
268 proteins (across tissue regions) with significant differences in peptide yield patterns
along their primary structures (Figure 2a; full PLF analysis reports: Tables S4–S6). When
compared to the proteins identified in the DIPPER study with significant differences in
relative abundance between aged and young samples (by label-free quantification) [13],
PLF identified 119 proteins that were unique to this approach, with significant differences
in protein structure but not abundance (Figure S3).
Figure 2. ECM-associated proteins make up half of the proteins identified with significant, age-
associated structural differences in all three IVD regions. PLF revealed 126 proteins in posterior
(Table S4), 117 in left lateral (Table S5) and 165 in anterior (Table S6) IVD regions with significant
differences in peptide yield between aged and young IVDs, across their structures. (a) Of these, 38
were shared between the three regions. (b) Classification of these shared proteins revealed ECM as
the major class, which included several ECM-associated proteins, collagens, two elastic fibre-specific
proteins and two proteoglycans. The affected proteins which were uniquely discovered by PLF and
not by label-free quantification of abundance in the DIPPER study [13] (Figure S3) are highlighted
in bold.
Of the 268 proteins identified with age-associated structural differences, 38 were
shared between posterior, lateral and anterior inner AF regions (Figure 2a). Classification
of these proteins into ECM-specific protein classes highlighted several matrix-associated
proteins, including the major structural collagens of the AF (collagen I [COL1A2] and V
[COL5A1]) and NP (collagen II [COL2A1] and VI [COL6A1]), elastic fibre-associated proteins
(fibrillin-1 [FBN1] and LTBP2 [LTBP2]) and proteoglycans such as aggrecan (ACAN] as
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key affected components (Figure 2b). Some of the identified proteins have been linked to
disease, including osteoarthritis-associated [28,29] cartilage intermediate layer proteins 1
and 2 (CILP and CILP2), the levels of which were shown to differ significantly between
degenerated and non-degenerated AFs and NPs [12], and cell-matrix adhesion-mediating
thrombospondins 2 [30] and 4 [31]. The levels of thrombospondin 4 (THBS4) were shown
previously in the DIPPER study to be significantly higher in the young inner AF than in
the aged one [13]. However, to our knowledge, age-associated structural differences in
disc thrombospondin have not been previously shown, although two single-nucleotide
polymorphisms were found to be associated with IVD degeneration [32].
The decline of the proteoglycan aggrecan in IVD ageing due to proteolysis by MMPs
and aggrecanases is well established [33]. Here, we show evidence of structural differences
within the aggrecan core protein between aged and young IVDs which may relate to these
mechanisms. Similarly, the degeneration of elastic fibre and collagen architectures are a
hallmark of ageing in many connective tissues such as IVD, skin and aorta [34–38]. Our
data show that, in the IVD, this process may possibly extend specifically to modification-
associated changes in the protein structures of elastic fibre proteins fibrillin-1 and latent
TGFβ-binding protein 2 and in multiple α-chains from collagens I, II, V, VI and XI.
To investigate whether the age-associated differences in peptide yield patterns along
the primary structure of ECM proteins are consistent between regions, members of these
38 shared, significantly different proteins were examined further.
2.2. Age-Associated Fluctuations in Peptide Yield along the Primary Structures of COL1A2 and
PCOLCE Are Markedly Conserved between Posterior, Lateral and Anterior IVD Regions
Both the collagen I α2 chain (COL1A2) and procollagen C-endopeptidase enhancer 1
(PCOLCE; PCPE1) were identified with age-associated modifications to their structures in
all three IVD regions (Figure 2b). COL1A2 is a major structural component of collagen I
fibrils, forming a tightly bound triple helix alongside two additional α1 chains (COL1A1)
within a monomer. The extracellular glycoprotein procollagen C-endopeptidase enhancer
1 (PCOLCE) binds to the C-terminal propeptide of procollagens and drives the activity of
tolloid proteinases, procollagen cleavage and their subsequent assembly into fibres [39].
PCOLCE therefore plays a crucial role in collagen deposition and associated morbidities
such as fibrosis [40].
Comparisons between posterior, lateral and anterior regions revealed notable, consis-
tent age-associated differences in peptide yield across the protein structures of COL1A2
and PCOLCE. On the C-terminal side of the COL1A2 protein, characteristic significant
increase and decrease in peptide yield pattern were observed in aged compared to young,
along the primary structure for all three IVD regions (Figure 3a). Similarly, a characteristic
increase in peptide yield was seen on the N-terminal side of aged PCOLCE compared to
young PCOLCE, followed by a significant decrease in peptide yield on the C-terminal side
(Figure 3b). This pattern was also consistent for posterior, lateral and anterior inner AF
regions. While there were age-associated differences observed along the structures of both
proteins, it is important to consider that peptide yields were also stable between aged and
young in many protein regions (such as on the N-terminal side of COL1A2). This lack of
difference between young and old was also consistent between IVD regions.
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Figure 3. COL1A2 and PCOLCE protein structures exhibit differences in peptide yield patterns
between young and aged proteins, which were conserved in posterior, left lateral and anterior IVD
regions. PSMs were summed in each 50-aa protein segment, normalised and averaged for young
and aged groups (bar graphs = average, normalised PSMs, error bars = standard deviation). Average
PSMs per segment in young were subtracted by those in aged and divided by segment aa length
(50) to reveal fluctuations in peptide yield along protein structures (line graph y axes = aged–young
PSM counts/segment length, normalised between tissue regions in composite graphs; * p ≤ 0.05;
** p ≤ 0.01; *** p ≤ 0.001, Bonferroni-corrected, repeated-measures ANOVA; black * in composite line
graph = significant in all three IVD regions; functional domains, sourced from UniProt, are indicated).
((a), i) Several COL1A2 segments exhibited significant differences in peptide yield between young
and aged samples within the C-terminal half of the protein (blue line: posterior, green: left lateral,
red: anterior). ((a), ii) Crucially, these differences in peptide yield along the COL1A2 structure are
markedly consistent between all the three regions, with a similarly higher peptide yield displayed in
segment 20 of aged compared to young and lower peptide yield in the last three segments, nearest
to the C-terminus. ((b), i) The last 50-aa segment on the C-terminal end of PCOLCE also exhibited
a significantly lower peptide yield in aged compared to young for the inner AFs of all three IVD
regions. ((b), ii) Peptide yield difference patterns along the primary structure were also similar
between all the three regions, with a consistently higher peptide yield in aged compared to young
measured on the N-terminal side of the protein followed by a lower yield in the last two segments
near the C-terminal end.
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The significantly higher peptide yield, observed on the C-terminal end of young
COL1A2 compared to the aged protein, corresponds directly to its non-collagenous (NC1)
domain (Figure 3a(ii)). These domains are cleaved prior to fibril assembly [41] by C-
proteinases such as bone morphogenic protein-1/tolloid proteinase (BMP1) from fully
folded procollagen, releasing a C-terminal propeptide. Since the release of this domain
is critical for the formation and assembly of the collagen triple helix protomer [42], its
higher detection in the young IVD suggests heightened collagen synthesis compared to the
aged one. Also in support of this, the significantly lower peptide yield in aged PCOLCE
compared to young PCOLCE, seen on its C-terminal end for all IVD regions, coincides
directly with its netrin (NTR) domain (Figure 3b(ii)), critical for the super-stimulation of
BMP1 and its cleavage of the collagen NC1 domain prior to fibril assembly [43]. This lower
peptide yield in the netrin domain of aged PCOLCE may impact on its interaction with
BMP1. It is possible that age-associated changes to PCOLCE structure may have resulted
in masking of this protein region, which would explain its lower availability to trypsin
and potentially BMP1, also impacting on collagen synthesis. Recent studies of collagen
turnover in healthy tendon have shown that collagen is not repaired [44,45] but instead
maintained daily, through a cycle of synthesis and degradation that is controlled by the
circadian rhythm [46]. It is likely that a similar maintenance program exists in young,
healthy AF (compositionally similar to tendon), and here, we show indications that this
may deteriorate with age.
A second COL1A2 protein region, located near the C-terminal end of the triple helical
domain (Figure 3a(ii)), also differed significantly between aged and young samples (higher
peptide yields in aged) for all three IVD regions. As this protein region is located well
within the triple helix of collagen I, peptides derived from this domain are likely to be from
mature collagen fibrils. In osteoporosis, fragments of the C-terminal telopeptide of collagen
I α1 are frequently used as markers of collagen degradation in bone [47,48]. Although
the COL1A2 protein region seen here is located upstream of its C-terminal telopeptide
(Figure 3a(ii), black arrow), a higher peptide yield in aged IVD may also be indicative of
collagen fibril degradation as a consequence of damage accumulation to structure. COL1A2
is a substrate for matrix metalloproteinases (MMPs) 1, 2, 3, 8 and 14 [49] (see interaction
network Figure S4), all of which were shown to be upregulated in degenerated IVD [50].
All of these enzymes (except MMP3) preferentially cleave the α-chains of collagens I, II
and III at a point approximately three-quarters of the way along the mature chain from
the N-terminus [51,52]. The COL1A2 region, which had higher peptide yields in aged
than in young samples, is located just downstream of this prominent MMP cleavage site
(indicated in Figure 3a(ii), black arrow) and corresponds to this degradation fragment,
cleaved three-quarters away from the N-terminus. This suggests that chronic exposure
to elevated endogenous MMPs, thought to be one of several ageing mechanisms driving
the accumulation of damage to long-lived ECM assemblies, could potentially be playing
a role in the higher peptide yield observed in the triple-helical domain of aged COL1A2
compared to young COL1A2.
In addition to BMP1, PCOLCE also binds fibronectin [53], LTBP1, thrombospondin
1, aggrecan and biglycan [54] (and their associated glycosaminoglycans), and COL1A2
binds COL5A1 [55] within the wider ECM network (Figure S4). If the structural differences
seen in aged PCOLCE and COL1A2 compared to the young molecules (Figure 3) result
in the impediment of these interactions, it could drive the deterioration of the wider
proteostasis [13].
The remarkable consistency in the age-associated peptide yield patterns of COL1A2
and PCOLCE structures between the posterior, lateral and anterior regions of the inner
AF (Figure 3) is an interesting observation, as it indicates the possibility that ageing
mechanisms may be at play tissue-wide. However, some proteins exhibited significant
structural differences in peptide yield, which were entirely tissue region-specific.
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2.3. Age-Associated Peptide Yield Patterns along the Primary Structures of the α1 Chains of
Collagens II and V and Aggrecan Exhibit Regional Tissue Specificity within the IVD
A sub-population of IVD proteins showed significant differences in structure which
were region-specific (42 for posterior, 50 for lateral and 74 for anterior) between young and
aged samples (Figure 4). These proteins included several prominent ECM components
such as tenascin (TNC) and proteoglycan 4 (PRG4) (exclusive to posterior), collagen XIV α1
(COL14A1) and osteomodulin (OMD) unique to left lateral) and EMILIN-1 (EMILIN1) and
nidogen 2 (NID2) (exclusive to anterior) (Figure S5).
Figure 4. A total of 166 proteins were identified with significant, age-associated structural differences
that were entirely IVD-region specific. The affected proteins which were uniquely discovered by
PLF and not by label-free quantification of abundance in the DIPPER study (Figure S3) [13] are
highlighted in bold.
Importantly, some proteins even displayed differences in peptide yield between young
and aged samples, which were shared between all AF regions (Figure 2b) on one side of
their protein structures but region-specific on the other side, as seen for collagen V α1
(COL5A1), collagen II α1 (COL2A1) and aggrecan core protein (ACAN) (Figure 5). For
COL5A1, a characteristic significant decrease in peptide yield in aged compared to young
samples, followed by an increase, can be seen in the C-terminal end, along the primary
structure, which remains consistent for all three IVD regions (Figure 5a). This is similar also
for COL2A1, which exhibited the same significant rise and fall in peptide yield along its
chain in all three IVD regions, on its C-terminal side (Figure 5b). However, both α1 chains
of collagens V and II displayed additional N-terminal, significant increases in peptide
yield in aged compared to young samples that were lateral-specific (green brackets in
Figure 5a,b(ii)). Contrastingly, a significantly higher peptide yield was observed near the
N-terminal end of aged aggrecan than in the young one, for both the posterior and the
anterior inner AF regions (Figure 5c). However, this pattern was reversed for left lateral,
with the same protein region yielding significant lower peptide counts in aged aggrecan
than in young aggrecan (green bracket in Figure 5c(ii)).
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Figure 5. COL5A1, COL2A1 and aggrecan all exhibit lateral, inner AF-specific differences in peptide
yield not seen in the posterior or anterior IVD regions. PSMs were summed in each 50-aa protein
segment, normalised and averaged for young and aged groups (bar graphs = average, normalised
PSMs, error bars = standard deviation). Average PSMs per segment in the young group were
subtracted by those in the aged one and divided by segment aa length (50) to reveal fluctuations
in peptide yield along protein structures (line graph y axes = aged–young PSM counts/segment
length, normalised between tissue regions in composite graphs; * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001,
Bonferroni-corrected, repeated-measures ANOVA; black * in composite line graph = significant in all
three IVD regions; functional domains, sourced from UniProt, are indicated). ((a), i) Several segments
Int. J. Mol. Sci. 2021, 22, 10408 11 of 17
on the C-terminal end of COL5A1 exhibited significant differences in peptide yields between young
and aged samples for all three IVD regions. However, a left lateral-specific significant difference in
yield was also observed in its second segment, on the N-terminal end of the protein. ((a), ii) Fluctua-
tions in COL5A1 peptide yield on the C-terminal end follow a similar pattern in all three regions,
with a consistent fall and rise of peptide yield observed in aged compared to young samples for the
last four segments of its primary structure. However, a clear left lateral-specific increase in peptide
yield can also be seen on the N-terminal end. ((b), i) COL2A1 also had several protein segments on
the C-terminal side which exhibited significant differences in peptide yield. ((b), ii) These displayed
a characteristic rise-and-fall peptide yield pattern in aged compared to young samples, which were
markedly consistent between the three IVD regions. However, once again, two COL2A1 segments
on the N-terminal side of the protein exhibited significantly higher yields for aged than for young
samples that were unique to the left lateral region of the disc. ((c), i) Segments two and three on the
N-terminal side of the aggrecan protein (ACAN) also exhibited significant differences in peptide
yield between young and aged samples. ((c), ii) These differences were significantly higher in aged
aggrecan within the posterior and anterior inner AF regions, compared to young aggrecan, but
significantly lower in the left lateral region.
The tissue region-conserved, higher peptide yields seen on the C-terminal ends of
young COL5A1 and COL2A1 compared to the aged one (Figure 5a,b(ii)) also corresponded
to their cleaved C-terminal propeptides, as seen for COL1A2 (Figure 3a(ii)). This once again
reflects a possible tissue-wide perturbation in collagen maintenance [46] in aged compared
to young discs, for collagen II and V fibrils in addition to collagen I. Interestingly, we noticed
that the C-terminal propeptides of COL1A2 and COL5A1 are enriched in ROS-sensitive
residues [56] (Figure S6), indicating a potential role for these fragments as antioxidants,
whose presence is reduced in aged IVD (Figures 3a and 5a(ii)). Again in common with
COL1A2 (Figure 3a(ii)), aged COL2A1 also exhibited an AF region-wide significant increase
in peptide yield compared to young COL2A1, downstream to a prominent MMP cleavage
site (Figure 5b(ii), black arrow) [51,52], possibly suggesting that chronic degradation of
collagen II by MMPs may be an ageing mechanism at play.
The lateral-specific, significant rise in peptide yield seen on the N-terminal end of aged
COL5A1 compared to young COL5A1 (green bracket in Figure 5a(ii)) corresponded partly
to its laminin G-like (LNS) domain [57]. Although capable of matriglycan interactions [58],
the function of this domain specifically within collagen V fibrils remains elusive. Here,
we show clear evidence that the binding availability of the LNS domain is significantly
higher exclusively in left lateral aged COL5A1 than for all other groups (young, aged and
posterior, anterior). For COL2A1, these aged, lateral-specific increases in peptide yield
(Figure 5b) corresponded directly to the interface between the N-terminal propeptide and
the triple-helical region, where the telopeptide is located. Collectively, these observations
in COL5A1 and COL2A1 may indicate the degradation of their respective collagen V and II
fibrils exclusively in the lateral regions of the AF.
The heightened peptide yield observed near the N-terminal end of aged posterior
and anterior ACAN compared to young ACAN, which was reversed (lower) for the aged
left lateral protein, coincides with the immunoglobulin fold of its globular G1-A domain
(Figure 5c(ii)), [33]. The A subdomain in particular is critical for stabilising and enhancing
the binding of its adjacent B subdomains to hyaluronan [59]. This interaction is crucial for
the anchorage of aggrecan to collagen fibrils in articular cartilage [60] (Figure S4). Several
ageing mechanisms have been suggested for age-related changes previously observed in
aggrecan structure. Interestingly, Sivan et al. proposed that, as a consequence of elevated
proteases in ageing discs, proteolysis on the N-terminal end of aggrecan results in only
the G1 domain remaining bound to the hyaluronan, which leads to the accumulation of
unbound aggrecan fragments in the NP [33]. Additionally, aged aggrecan is known to
accumulate AGEs on its lysine residues in vivo [37], and lysine residues within the G1
domain are critical for its hyaluronan interaction [33]. Collectively, these insights highlight
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the functional importance of this N-terminal protein region in aggrecan and may provide
clues for the mechanisms (e.g., proteolysis or glycation) behind the tissue region-specific
differences in peptide yield observed within this protein region between aged and young
samples.
It is important to note that these displays of tissue region-specific modifications
to protein structures were not limited to ECM proteins. For instance, similar peptide
pattern differences were observed within the immune regulator complement factor H
(CFH) (Figure S7), which also exhibited anterior inner AF-specific regional difference
between young and aged samples, on the C-terminal side of its primary structure, and also
tissue region-wide differences near its N-terminus. CFH plays a key role in regulating the
progression of inflammation in age-related diseases such as vascular atherosclerosis [61]
and macular degeneration [62]. The structural modifications observed here suggest that
similar CFH-driven inflammation pathways may be involved in regions of the inner AF.
Collectively, these observations indicate not only the possibility of regional down-
stream consequences of ageing to major ECM components, on a molecular level, but also
the potential of mechanisms acting exclusively within specific IVD regions.
3. Materials and Methods
3.1. Dataset Collection
In this study, young and aged IVD LC–MS/MS datasets were sourced from the
Proteomics Identification Database (PRIDE)—Project ID PXD017740. These were originally
generated for an earlier study which led to the spatiotemporal IVD proteomic resource
DIPPER—http://www.sbms.hku.hk/dclab/DIPPER/ (last accessed 13 September 2021).
For detailed methods of human tissue sourcing, sample preparation and MS, please refer
to this original publication [13]. In brief, the datasets were generated by LC–MS/MS
(data-dependant acquisition on an Orbitrap Fusion Lumos Tribrid Mass Spectrometer)
from trypsin/LysC-digested whole protein samples extracted from 11 separate regions
of IVDs—three discs (L3/4, L4/5 and L5/S1)—sourced from two male cadaveric human
lumbar spines, one young (16-year-old) and one aged (59-year-old). Prior to LC–MS/MS,
peptides were fractionated into four samples per IVD region by high-pH reversed-phase
peptide fractionation and separately analysed. For this study, only 3 out of the 11 IVD
regions available for analysis were evaluated by PLF: the anterior, left lateral and posterior
inner AF/NPs (Figure 1a). PLF measures the relative difference in regional digestibility
within proteins between two groups, and so it is important to note that the more preserved
the native quaternary structure of the protein is, the more differences should be identifiable
using this approach. Unfortunately, all protein extraction methods will inherently change
the higher order structure of a protein. However, because all proteins in the samples
tested were originally extracted using identical sample preparation methods [13], the
regional differences measured are therefore a direct reflection of their native structure,
prior to extraction. For this reason, PLF can be applied to historic datasets regardless of the
extraction protocol used, as we have shown previously for ageing tendon [25].
It is important to highlight that the acquisition of non-degenerated human IVD tissue
is challenging, and such samples from young and aged individuals are rare. Although
we acknowledge that this detailed analysis was performed on one young and one aged
individual only, this limitation is outweighed by the merits of the study, since our findings
are based on human in vivo data and, therefore, of direct clinical relevance.
3.2. Peptide Identification
Raw MS spectrum files were converted to Mascot MGF files using RawConverter (Scripps
Research Institute, La Jolla, CA, USA) [63], and peak spectra searched against the Uniprot
human database (Swiss-Prot and TreEMBL; 2018) [64] using Mascot (Matrix Science, MA,
USA). MS/MS ion searches were performed using the following parameters—instrument:
ESI-TRAP; database: Swissprot_TreEMBL_2018_01; species: Homo sapiens (161,629 protein
isoforms); fragment tolerance: 20 ppm; parent tolerance: 6 ppm (monoisotopic); fixed mod-
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ifications: +58 Da on C (carboxymethyl); variable modifications: +16 Da on M (oxidation);
digestion enzyme: trypsin; max missed cleavages: 2; peptide charge: 2+, 3+ and 4+. Mascot
search results were exported as DAT files.
Scaffold 5 (Proteome Software, Portland, OR, USA) was then used to generate high-
confidence PSMs by standard LFDR scoring. Mascot DAT files were imported into Scaffold
5, and individual fractionated peptide sample datasets were combined to form a single
IVD region sample dataset using MudPIT (Stowers Institute, Kansas, MO, USA) [65].
Only peptides exclusive to their matched proteins and with a peptide probability of
95% minimum were used for PLF analysis, giving a low false discovery rate (FDR) of
0.6% per group (posterior, left lateral and anterior). Peptide FDR was calculated by the
PeptideProphet algorithm (open source: http://peptideprophet.sourceforge.net/, accessed
on 13 September 2021) [66] within Scaffold 5 using peptide probabilities designated by the
Trans-Proteomic Pipeline. CSV files containing peptide lists were exported from Scaffold 5
for PLF analysis (Tables S1–S3).
3.3. Peptide Location Fingerprinting
Peptide lists were imported into our MPLF webtool (accessible at https://www.
manchesterproteome.manchester.ac.uk/#/MPLF) (accessed on 13 September 2021), and
three separate PLF analyses were performed on young vs. aged molecules for each IVD
region (posterior, left lateral and anterior). As previously described [25] (Figure 1b), protein
primary sequences were computationally divided into 50-aa-sized segments, and peptide
sequences and their spectrum counts were mapped and summed within each segment.
Sequences spanning two adjoining segments were counted in both. In order to identify
differences in peptide yield along protein structures that are independent of differences in
whole protein abundance, peptide counts in each 50-aa segment were normalised based on
the experiment-wide (young and aged), median whole spectrum count of its corresponding
protein. As a result of this protein-specific normalisation, each protein was treated as
its own separate experiment during statistical comparison. Average, normalised peptide
counts in each segment for the young group were subtracted from those in the aged group
and divided by the segment aa length (50) to reveal regional fluctuations in peptide yield
within the primary structures of proteins. Average, normalised peptide counts per protein
segment were statistically compared between young and aged groups using unpaired,
Bonferroni-corrected, repeated-measures ANOVAs (Tables S4–S6). Proteins which were
only present in one group (young or aged) were excluded from the analysis. For more
information on PLF and the MPLF webtool, please refer to our earlier publication [25].
3.4. Interaction Network Analysis
Exemplar proteins COL1A2, PCOLCE, COL5A1, COL2A1 and aggrecan were used
to construct an experimentally identified interaction network (Figure S4). ECM protein
interactions were derived using Matrix DB [67], which were constructed and visualised
using Cytoscape 3.4.0. (open source: https://cytoscape.org/, accessed on 13 September
2021) [68].
4. Conclusions
Although ageing and degeneration of IVDs are the result of genetics, environments
and their interplays [5], this study focused predominantly on the identification of ECM
proteins that may have accumulated modifications to structure over time. This was suc-
cessfully enabled through the application of PLF to historic LC–MS/MS datasets generated
from the inner AF of posterior, lateral and anterior regions of young and aged human
IVDs. We demonstrated that, although many of these affected proteins were region-specific,
several were identified in all three regions tested. Some of these shared proteins, such
as COL1A2 and PCOLCE, exhibited remarkably consistent age-associated differences in
peptide yields along their protein structures between all tissue regions. This indicates the
possibility that the same mechanisms of ageing may act on proteins across the entire tissue,
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leading to similar molecular-level consequences. However, several proteins identified,
such as COL5A1, COL2A1 and ACAN, also had lateral-specific differences in structure
between aged and young samples, which indicates the possibility that some mechanisms
acting on proteins may also be exclusive to certain tissue regions. This suggests that protein
structures are potentially spatially and age-dependent in the IVD and that PLF is capable of
detecting differences within localised tissue regions. This study highlights the merits of PLF
as an interrogator of structural changes within proteins and potentially as a powerful tool
for aiding biomarker discovery [25], which, in tandem with relative protein quantification
(achieved in the DIPPER study [13]), allows for a more complete assessment of tissue
proteostasis.
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